SCHEMBL2363294

SCHEMBL2363294

CCCCC/C=C/P(=O)(OCC)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 3/20 0.55
LPAR1 Q92633 2/20 0.44
LPAR2 Q9HBW0 2/20 0.44
FAAH O00519 5/20 0.42
TRPV1 Q8NER1 2/20 0.42
GGPS1 O95749 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
PLA2G4A P47712 1/20 0.41
PAFAH1B2 P68402 1/20 0.41
KMT2A Q03164 1/20 0.41
MGLL Q99685 1/20 0.41
ABHD6 Q9BV23 1/20 0.41
TSHR P16473 1/20 0.39
S1PR4 O95977 2/20 0.39
S1PR1 P21453 2/20 0.39
S1PR3 Q99500 2/20 0.39
S1PR5 Q9H228 2/20 0.39
S1PR2 O95136 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2363295 1.00 LPAR3 (0.55) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL11273413 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL28965481 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL8052980 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL11447222 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL6542265 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL11273408 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL8052984 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL21638735 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1
SCHEMBL11447221 0.98 LPAR3 (0.53) LPAR3LPAR1LPAR2FAAHTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260382-B2 Methods of reducing virulence in bacteria UWM RESEARCH FOUNDATION (US) 2016-02-16 US disclosed
EP-2536275-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA UWM Research Foundation, Inc. (US) 2012-12-26 EP disclosed
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA DUKE UNIVERSITY (US) 2012-12-20 US disclosed
WO-2011103189-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA UWM RESEARCH FOUNDATION, INC. (US) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA PGLS, RRS1, MRPL21 LPAR3 2828/4885LPAR1 2542/4885LPAR2 3263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.